Intranasal GHRP-2 effectively stimulated GH release in children with short stature, offering a needle-free alternative to injectable GH therapy.
Needle-free GH stimulationIntranasal GHRP-2 effectively stimulated GH release in children, offering an alternative to daily injections
What the researchers found
Intranasal GHRP-2 effectively stimulated GH release in children with short stature, demonstrating viability of a needle-free delivery route.
Why it matters
For children who need GH therapy, a nasal spray could eliminate the need for daily injections — a major quality-of-life improvement for pediatric patients.
How the study worked
Clinical trial administering intranasal GHRP-2 to children with short stature and measuring GH responses.
What this study cannot tell us
Clinical trial; specific treatment outcomes, dosing, duration, and sample size not detailed in abstract. Long-term growth effects not assessed.
How to read the evidence
Moderate clinical evidence from a pediatric trial. Demonstrates intranasal efficacy but long-term treatment effects not assessed.
When this study was published
Published in 1997, this study explored intranasal GHRP delivery that has since informed peptide nasal spray development.
The bigger picture
Intranasal peptide delivery represents a major advance in pediatric endocrinology, potentially replacing painful daily injections with a simple nasal spray.
Questions still open
- Does intranasal GHRP-2 produce sufficient GH stimulation for long-term growth improvement?
- How does intranasal bioavailability compare to subcutaneous injection?
Common questions
Can GHRP-2 be taken as a nasal spray?
Why is this important for children?
Read the original research
Treatment effects of intranasal growth hormone releasing peptide-2 in children with short stature.
The Journal of endocrinology, 155(1), 79-86
Citation
Pihoker, C; Badger, T M; Reynolds, G A; Bowers, C Y. (1997). Treatment effects of intranasal growth hormone releasing peptide-2 in children with short stature.. The Journal of endocrinology, 155(1), 79-86.